1Hardy W D J. Hematopoietic tumors of cats[J]. J Am Anim Hosp Assoc, 1981a,17:921-940.
2Bennett J M. Recommendations for morphologic, immunolog-ic and cytogenetic (MIC) working classification of primary and therapy-related myelodysplastic disorders[J]. Cancer Genet Cytogenet, 1988, 32:1.
3Berrebi A, Ladiges W C, Custer R P, et al. Further characte-rization of prolym phocytic leukemia cells as a tumor of activated B cells. Am J Hematol [J]. 1990, 34: 181.
4Pui C H, Evans W E .Acute lymphoblastic leukemia[J].Ellgl J Med, 1998, 339(9):605.
5Zeytum A, Nagarkatti M, Nagarkatti P S. Growth of Fas L-bearing tumor cells in syngeneic murine hos tinduces apoptosis and toxicity in Fas+ organs[J].Blood, 2000, 95(6):2111-2117.
6Hildebrand F L, A Rosenow E C, Habermann T M, et al. P-ulmonary complication of leukemla[J]. Chest, 1990,98:1233.
7Thalhammer-Scherrer R,Mitterbauer G,Simonitsch I, et al. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination[J
2[2]Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, et al. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol, 2002, 117(3):380
3[4]Lo Coco F, Foa R. Diagnostic and prognostic advances in the immunophenotypic and genetic characterization of acute leukaemia. Eur J Haematol, 1995, 55(1):1
4[5]Huh YO, Ibrahim S. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am, 2000,14(6):1251
5[6]Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, et al. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol, 2001,68(2):69
6[7]Piedras J, Lopez-Karpovitch X, Cardenas MR, et al. Cellular immunophenotypes in 97 adults with acute leukemia. Rev Invest Clin, 1997,49(6):457
